Literature DB >> 15252033

The anticoagulant thrombin mutant W215A/E217A has a collapsed primary specificity pocket.

Agustin O Pineda1, Zhi-Wei Chen, Sonia Caccia, Angelene M Cantwell, Savvas N Savvides, Gabriel Waksman, F Scott Mathews, Enrico Di Cera.   

Abstract

The thrombin mutant W215A/E217A features a drastically impaired catalytic activity toward chromogenic and natural substrates but efficiently activates the anticoagulant protein C in the presence of thrombomodulin. As the remarkable anticoagulant properties of this mutant continue to be unraveled in preclinical studies, we solved the x-ray crystal structures of its free form and its complex with the active site inhibitor H-d-Phe-Pro-Arg-CH(2)Cl (PPACK). The PPACK-bound structure of W215A/E217A is identical to the structure of the PPACK-bound slow form of thrombin. On the other hand, the structure of the free form reveals a collapse of the 215-217 strand that crushes the primary specificity pocket. The collapse results from abrogation of the stacking interaction between Phe-227 and Trp-215 and the polar interactions of Glu-217 with Thr-172 and Lys-224. Other notable changes are a rotation of the carboxylate group of Asp-189, breakage of the H-bond between the catalytic residues Ser-195 and His-57, breakage of the ion pair between Asp-222 and Arg-187, and significant disorder in the 186- and 220-loops that define the Na(+) site. These findings explain the impaired catalytic activity of W215A/E217A and demonstrate that the analysis of the molecular basis of substrate recognition by thrombin and other proteases requires crystallization of both the free and bound forms of the enzyme.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15252033     DOI: 10.1074/jbc.M407272200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

Review 1.  Conformational selection in trypsin-like proteases.

Authors:  Nicola Pozzi; Austin D Vogt; David W Gohara; Enrico Di Cera
Journal:  Curr Opin Struct Biol       Date:  2012-06-03       Impact factor: 6.809

2.  Thrombin mutant W215A/E217A treatment improves neurological outcome and reduces cerebral infarct size in a mouse model of ischemic stroke.

Authors:  Michelle A Berny-Lang; Sawan Hurst; Erik I Tucker; Leslie A Pelc; Ruikang K Wang; Patricia D Hurn; Enrico Di Cera; Owen J T McCarty; András Gruber
Journal:  Stroke       Date:  2011-04-21       Impact factor: 7.914

3.  Structural identification of the pathway of long-range communication in an allosteric enzyme.

Authors:  Prafull S Gandhi; Zhiwei Chen; F Scott Mathews; Enrico Di Cera
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-04       Impact factor: 11.205

4.  Stabilization of the E* form turns thrombin into an anticoagulant.

Authors:  Alaji Bah; Christopher J Carrell; Zhiwei Chen; Prafull S Gandhi; Enrico Di Cera
Journal:  J Biol Chem       Date:  2009-05-27       Impact factor: 5.157

5.  Selectivity and cooperativity of modulatory ions in a neurotransmitter receptor.

Authors:  Ranjit Vijayan; Andrew J R Plested; Mark L Mayer; Philip C Biggin
Journal:  Biophys J       Date:  2009-03-04       Impact factor: 4.033

6.  Mechanism of the anticoagulant activity of thrombin mutant W215A/E217A.

Authors:  Prafull S Gandhi; Michael J Page; Zhiwei Chen; Leslie Bush-Pelc; Enrico Di Cera
Journal:  J Biol Chem       Date:  2009-07-08       Impact factor: 5.157

Review 7.  Allostery in trypsin-like proteases suggests new therapeutic strategies.

Authors:  David W Gohara; Enrico Di Cera
Journal:  Trends Biotechnol       Date:  2011-07-02       Impact factor: 19.536

8.  Design of Factor XIII V34X activation peptides to control ability to interact with thrombin mutants.

Authors:  Madhavi A Jadhav; R Cory Lucas; Whitney N Goldsberry; Muriel C Maurer
Journal:  Biochim Biophys Acta       Date:  2011-07-21

Review 9.  Serine proteases.

Authors:  Enrico Di Cera
Journal:  IUBMB Life       Date:  2009-05       Impact factor: 3.885

10.  Interaction between thrombin mutant W215A/E217A and direct thrombin inhibitor.

Authors:  Kenichi A Tanaka; Andras Gruber; Fania Szlam; Leslie A Bush; Stephen R Hanson; Enrico Di Cera
Journal:  Blood Coagul Fibrinolysis       Date:  2008-07       Impact factor: 1.276

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.